Mahesh N. Samtani - Concepedia

Author

Mahesh N. Samtani

Also Known As

Allitia DiBernardo, M Samtani, M. Samtani, M.N. Samtani, Mahesh N. Samtani, Mahesh N Samtani, Mahesh N. Samtani, Mahesh Samtani, Xu Steven Xu

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Johnson & Johnson (United States)University at Buffalo, State University of New York Janssen (Belgium)Springhouse

About

Mahesh N. Samtani is an author at Janssen (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	460
2	Health Sciences	2	2	48
3	Social Sciences	1	1	166
4	Biochemistry	1	1	23
5	Biostatistics	1	1	46

Mahesh N. Samtani

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia Mahesh N. Samtani, An Vermeulen, Kim Stuyckens Clinical Pharmacokinetics PsychiatryPsychotic DisorderMedicinePsychopharmacologySchizophrenia	2009	166
The ADAS‐Cog revisited: Novel composite scales based on ADAS‐Cog to improve efficiency in MCI and early AD trials Nandini Raghavan, Mahesh N. Samtani, Michael Farnum, Alzheimer s & Dementia	2012	94
Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist <scp>JNJ</scp>‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging study Maria Alba, Jaqueline Yee, Mary Ellen Frustaci, Clinical Obesity	2021	87
Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3‐month formulation in patients with schizophrenia: A phase‐1, single‐dose, randomized, open‐label study Paulien Ravenstijn, Bart Remmerie, Adam Savitz, The Journal of Clinical Pharmacology	2015	84
An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative Mahesh N. Samtani, Michael Farnum, Victor S. Lobanov, The Journal of Clinical Pharmacology	2011	81
Quantifying the Pathophysiological Timeline of Alzheimer's Disease Eric Yang, Michael Farnum, Victor S. Lobanov, Journal of Alzheimer s Disease	2011	69
A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia Danielle Coppola, Yanning Liu, Srihari Gopal, BMC Psychiatry	2012	60
Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration Mahesh N. Samtani, William J. Jusko Biopharmaceutics & Drug Disposition	2005	57
BETAMETHASONE PHARMACOKINETICS AFTER TWO PRODRUG FORMULATIONS IN SHEEP: IMPLICATIONS FOR ANTENATAL CORTICOSTEROID USE Mahesh N. Samtani, Matthias Löhle, Angela Grant, Drug Metabolism and Disposition	2005	57
Disease progression model for Clinical Dementia Rating&ndash;Sum of Boxes in mild cognitive impairment and Alzheimer&rsquo;s subjects from the Alzheimer&rsquo;s Disease Neuroimaging Initiative Mahesh N. Samtani, Nandini Raghavan, Gerald Novak, Neuropsychiatric Disease and Treatment	2014	56

Page 1